Fentanyl Citrate | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Grow Your Pharma Business Digitally

X

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Fentanyl Citrate
US Patents

PharmaCompass Sponsored Ads

Contact Supplier

Veranova Fentanyl Citrate

Contact Supplier

xyz-pharma-m-2025-03-24

Contact Supplier

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Contact Supplier

Gentec Pharmaceutical Group is focused on manufacturing & developing APIs/HPAPIs, Advanced Intermediates & Fine Chemicals.

Contact Supplier

xyz-pharma-m-2025-03-17

Contact Supplier

Fentanyl Citrate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

31 API Suppliers, 14 USDMF, 12 CEP/COS, 4 JDMF, 3 EU WC, 4 KDMF, 16 NDC API, 16 Listed Suppliers, $ API Reference Price

31 API Suppliers
14 USDMF
12 CEP/COS
4 JDMF
3 EU WC
4 KDMF
16 NDC API
16 Listed Suppliers
$ API Reference Price

FINISHED DOSAGE FORMULATIONS

379 FDF Dossiers, 77 FDA Orange Book, 159 Europe, 25 Canada, 75 Australia, 17 South Africa, 26 Listed Dossiers

379 FDF Dossiers
77 FDA Orange Book
159 Europe
25 Canada
75 Australia
17 South Africa
26 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TROCHE/LOZENGE;TRANSMUCOSAL - EQ 0.2MG BASE, TROCHE/LOZENGE;TRANSMUCOSAL - EQ 0.4MG BASE, TROCHE/LOZENGE;TRANSMUCOSAL - EQ 0.6MG BASE, TROCHE/LOZENGE;TRANSMUCOSAL - EQ 0.8MG BASE, TROCHE/LOZENGE;TRANSMUCOSAL - EQ 1.2MG BASE, TROCHE/LOZENGE;TRANSMUCOSAL - EQ 1.6MG BASE, TABLET;BUCCAL, SUBLINGUAL - EQ 0.1MG BASE, TABLET;BUCCAL, SUBLINGUAL - EQ 0.2MG BASE, TABLET;BUCCAL, SUBLINGUAL - EQ 0.3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;BUCCAL, SUBLINGUAL - EQ 0.4MG BASE, TABLET;BUCCAL, SUBLINGUAL - EQ 0.6MG BASE, TABLET;BUCCAL, SUBLINGUAL - EQ 0.8MG BASE, TABLET;SUBLINGUAL - EQ 0.1MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;SUBLINGUAL - EQ 0.2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;SUBLINGUAL - EQ 0.3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;SUBLINGUAL - EQ 0.4MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;SUBLINGUAL - EQ 0.6MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;SUBLINGUAL - EQ 0.8MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SPRAY, METERED;NASAL - EQ 0.1MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SPRAY, METERED;NASAL - EQ 0.3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SPRAY, METERED;NASAL - EQ 0.4MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TROCHE/LOZENGE;TRANSMUCOSAL - EQ 0.2MG BASE
TROCHE/LOZENGE;TRANSMUCOSAL - EQ 0.4MG BASE
TROCHE/LOZENGE;TRANSMUCOSAL - EQ 0.6MG BASE
TROCHE/LOZENGE;TRANSMUCOSAL - EQ 0.8MG BASE
TROCHE/LOZENGE;TRANSMUCOSAL - EQ 1.2MG BASE
TROCHE/LOZENGE;TRANSMUCOSAL - EQ 1.6MG BASE
TABLET;BUCCAL, SUBLINGUAL - EQ 0.1MG BASE
TABLET;BUCCAL, SUBLINGUAL - EQ 0.2MG BASE
TABLET;BUCCAL, SUBLINGUAL - EQ 0.3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;BUCCAL, SUBLINGUAL - EQ 0.4MG BASE
TABLET;BUCCAL, SUBLINGUAL - EQ 0.6MG BASE
TABLET;BUCCAL, SUBLINGUAL - EQ 0.8MG BASE
TABLET;SUBLINGUAL - EQ 0.1MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;SUBLINGUAL - EQ 0.2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;SUBLINGUAL - EQ 0.3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;SUBLINGUAL - EQ 0.4MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;SUBLINGUAL - EQ 0.6MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;SUBLINGUAL - EQ 0.8MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SPRAY, METERED;NASAL - EQ 0.1MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SPRAY, METERED;NASAL - EQ 0.3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SPRAY, METERED;NASAL - EQ 0.4MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 Rochem International Inc, 18 SPI Pharma, 2 DKSH, 4 Faran Shimi Pharmaceutical, 2 Boai NKY Pharmaceuticals Ltd, 6 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 1 ACG Worldwide, 6 Actylis, 1 Alcedo Pharmachem, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 4 BASF, 10 Corel Pharma Chem, 4 DFE Pharma, 1 Finar, 5 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 5 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 17 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 11 Microlex e.U, 2 Novo Excipients, 2 Pharmatrans-Sanaq, 4 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 18 Roquette, 8 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 2 The Dow Chemical Company, 1 Valens Pharmachem, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

55 Fillers, Diluents & Binders, 42 Coating Systems & Additives, 30 Disintegrants & Superdisintegrants, 27 Direct Compression, 22 Controlled & Modified Release, 19 Thickeners and Stabilizers, 18 Taste Masking, 16 Chewable & Orodispersible Aids, 16 Granulation, 13 Co-Processed Excipients, 10 Lubricants & Glidants, 10 Film Formers & Plasticizers, 9 Parenteral, 6 Solubilizers, 5 Rheology Modifiers, 5 Empty Capsules, 4 Vegetarian Capsules, 4 API Stability Enhancers, 3 Emulsifying Agents, 3 Topical, 2 Coloring Agents

55 Fillers, Diluents & Binders
42 Coating Systems & Additives
30 Disintegrants & Superdisintegrants
27 Direct Compression
22 Controlled & Modified Release
19 Thickeners and Stabilizers
18 Taste Masking
16 Chewable & Orodispersible Aids
16 Granulation
13 Co-Processed Excipients
10 Lubricants & Glidants
10 Film Formers & Plasticizers
9 Parenteral
6 Solubilizers
5 Rheology Modifiers
5 Empty Capsules
4 Vegetarian Capsules
4 API Stability Enhancers
3 Emulsifying Agents
3 Topical
2 Coloring Agents

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 36 News #PharmaBuzz

1 Data Compilation #PharmaFlow
36 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 103 Regulatory FDF Prices

2 US Medicaid Prescriptions
103 Regulatory FDF Prices

MARKET PLACE

12 APIs, 5 FDF Dossiers

12 APIs
5 FDF Dossiers

PATENTS & EXCLUSIVITIES

18 US Patents, 17 Health Canada Patents

18 US Patents
17 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 1 USP, 3 Others

2 EDQM
1 USP
3 Others

$ API Ref.Price (USD/KG) : 64,860 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

18 All

01 5ADALVO

02 3BTCP PHARMA

03 10CEPHALON

filter Patent Number Reset all filters

18 All

01 57862832

02 57862833

03 59597288

04 39731869

filter API Patent Reset all filters

18 All

01 18Blank

filter FDF Patent Reset all filters

18 All

01 18Y

filter Expiration Date Reset all filters

18 All

01 52027-07-23

02 102028-06-15

03 32032-01-26

Aspen Fentanyl Citrate

Product Main Page

01

ADALVO

FENTANYL CITRATE

ELCC

Not Confirmed

ADALVO

ELCC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-07-23

FENTANYL CITRATE

US Patent Number : 9597288

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22266

Patent Use Code : U-767

Delist Requested :

Patent Use Description : MANAGEMENT OF BREAKTHR...

Patent Expiration Date : 2027-07-23

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

ADALVO

FENTANYL CITRATE

ELCC

Not Confirmed

ADALVO

ELCC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-07-23

FENTANYL CITRATE

US Patent Number : 9597288

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22266

Patent Use Code : U-767

Delist Requested :

Patent Use Description : MANAGEMENT OF BREAKTHR...

Patent Expiration Date : 2027-07-23

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

ADALVO

FENTANYL CITRATE

ELCC

Not Confirmed

ADALVO

ELCC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-07-23

FENTANYL CITRATE

US Patent Number : 9597288

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22266

Patent Use Code : U-767

Delist Requested :

Patent Use Description : MANAGEMENT OF BREAKTHR...

Patent Expiration Date : 2027-07-23

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

ADALVO

FENTANYL CITRATE

ELCC

Not Confirmed

ADALVO

ELCC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-07-23

FENTANYL CITRATE

US Patent Number : 9597288

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22266

Patent Use Code : U-767

Delist Requested :

Patent Use Description : MANAGEMENT OF BREAKTHR...

Patent Expiration Date : 2027-07-23

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

ADALVO

FENTANYL CITRATE

ELCC

Not Confirmed

ADALVO

ELCC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-07-23

FENTANYL CITRATE

US Patent Number : 9597288

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22266

Patent Use Code : U-767

Delist Requested :

Patent Use Description : MANAGEMENT OF BREAKTHR...

Patent Expiration Date : 2027-07-23

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

CEPHALON

FENTANYL CITRATE

ELCC

Not Confirmed

CEPHALON

ELCC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-06-15

FENTANYL CITRATE

US Patent Number : 7862832

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 21947

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-06-15

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

CEPHALON

FENTANYL CITRATE

ELCC

Not Confirmed

CEPHALON

ELCC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-06-15

FENTANYL CITRATE

US Patent Number : 7862833

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 21947

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-06-15

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

CEPHALON

FENTANYL CITRATE

ELCC

Not Confirmed

CEPHALON

ELCC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-06-15

FENTANYL CITRATE

US Patent Number : 7862832

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 21947

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-06-15

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

CEPHALON

FENTANYL CITRATE

ELCC

Not Confirmed

CEPHALON

ELCC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-06-15

FENTANYL CITRATE

US Patent Number : 7862833

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 21947

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-06-15

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

CEPHALON

FENTANYL CITRATE

ELCC

Not Confirmed

CEPHALON

ELCC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-06-15

FENTANYL CITRATE

US Patent Number : 7862833

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 21947

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-06-15

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!